These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 1370198)

  • 1. Abnormalities in the regulation of vasopressin and corticotropin releasing factor secretion in obsessive-compulsive disorder.
    Altemus M; Pigott T; Kalogeras KT; Demitrack M; Dubbert B; Murphy DL; Gold PW
    Arch Gen Psychiatry; 1992 Jan; 49(1):9-20. PubMed ID: 1370198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebrospinal fluid neurochemistry in children and adolescents with obsessive-compulsive disorder.
    Swedo SE; Leonard HL; Kruesi MJ; Rettew DC; Listwak SJ; Berrettini W; Stipetic M; Hamburger S; Gold PW; Potter WZ
    Arch Gen Psychiatry; 1992 Jan; 49(1):29-36. PubMed ID: 1370197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in cerebrospinal fluid neurochemistry during treatment of obsessive-compulsive disorder with clomipramine.
    Altemus M; Swedo SE; Leonard HL; Richter D; Rubinow DR; Potter WZ; Rapoport JL
    Arch Gen Psychiatry; 1994 Oct; 51(10):794-803. PubMed ID: 7524463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vasopressin in CSF and plasma in depressed suicide attempters: preliminary results.
    Brunner J; Keck ME; Landgraf R; Uhr M; Namendorf C; Bronisch T
    Eur Neuropsychopharmacol; 2002 Oct; 12(5):489-94. PubMed ID: 12208567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma and cerebrospinal fluid measures of arginine vasopressin secretion in patients with bulimia nervosa and in healthy subjects.
    Demitrack MA; Kalogeras KT; Altemus M; Pigott TA; Listwak SJ; Gold PW
    J Clin Endocrinol Metab; 1992 Jun; 74(6):1277-83. PubMed ID: 1592871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated cerebrospinal fluid levels of oxytocin in obsessive-compulsive disorder. Comparison with Tourette's syndrome and healthy controls.
    Leckman JF; Goodman WK; North WG; Chappell PB; Price LH; Pauls DL; Anderson GM; Riddle MA; McSwiggan-Hardin M; McDougle CJ
    Arch Gen Psychiatry; 1994 Oct; 51(10):782-92. PubMed ID: 7524462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abnormalities in plasma and cerebrospinal-fluid arginine vasopressin in patients with anorexia nervosa.
    Gold PW; Kaye W; Robertson GL; Ebert M
    N Engl J Med; 1983 May; 308(19):1117-23. PubMed ID: 6835335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clomipramine treatment of obsessive-compulsive disorder. II. Biochemical aspects.
    Thorén P; Asberg M; Bertilsson L; Mellström B; Sjöqvist F; Träskman L
    Arch Gen Psychiatry; 1980 Nov; 37(11):1289-94. PubMed ID: 6159865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CSF somatostatin in obsessive-compulsive disorder.
    Altemus M; Pigott T; L'Heureux F; Davis CL; Rubinow DR; Murphy DL; Gold PW
    Am J Psychiatry; 1993 Mar; 150(3):460-4. PubMed ID: 8094599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated cerebrospinal fluid corticotropin-releasing factor in Tourette's syndrome: comparison to obsessive compulsive disorder and normal controls.
    Chappell P; Leckman J; Goodman W; Bissette G; Pauls D; Anderson G; Riddle M; Scahill L; McDougle C; Cohen D
    Biol Psychiatry; 1996 May; 39(9):776-83. PubMed ID: 8731518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vasopressin-dependent flank marking in golden hamsters is suppressed by drugs used in the treatment of obsessive-compulsive disorder.
    Ferris CF; Rasmussen MF; Messenger T; Koppel G
    BMC Neurosci; 2001; 2():10. PubMed ID: 11545675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Secretion of corticotropin releasing factor (CRF) and vasopressin (AVP) into the hypophysial portal blood of conscious, unrestrained rams.
    Caraty A; Grino M; Locatelli A; Oliver C
    Biochem Biophys Res Commun; 1988 Sep; 155(2):841-9. PubMed ID: 3048263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of plasma osmolality on pituitary-adrenal responses to corticotropin-releasing hormone and atrial natriuretic peptide changes in central diabetes insipidus.
    Elias LL; Antunes-Rodrigues J; Elias PC; Moreira AC
    J Clin Endocrinol Metab; 1997 Apr; 82(4):1243-7. PubMed ID: 9100602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebrospinal fluid corticotropin-releasing hormone, vasopressin, and oxytocin concentrations in treated patients with major depression and controls.
    Pitts AF; Samuelson SD; Meller WH; Bissette G; Nemeroff CB; Kathol RG
    Biol Psychiatry; 1995 Sep; 38(5):330-5. PubMed ID: 7495928
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of the serotonin reuptake inhibitor fluoxetine on corticotropin-releasing factor and vasopressin secretion into hypophysial portal blood.
    Gibbs DM; Vale W
    Brain Res; 1983 Nov; 280(1):176-9. PubMed ID: 6317143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced monoaminergic neurotransmission by desglycinamide-arginine-vasopressin in human subjects.
    Jolkkonen J; Lehtinen M; Soininen H; Sennef C; Riekkinen P
    Neurosci Lett; 1987 May; 76(3):312-5. PubMed ID: 2438607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of administration of corticotropin-releasing hormone and glucocorticoid on arginine vasopressin response to osmotic stimulus in normal subjects and patients with hypocorticotropinism without overt diabetes insipidus.
    Yamada K; Tamura Y; Yoshida S
    J Clin Endocrinol Metab; 1989 Aug; 69(2):396-401. PubMed ID: 2546964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebrospinal fluid corticotropin-releasing factor concentrations in patients with anxiety disorders and normal comparison subjects.
    Fossey MD; Lydiard RB; Ballenger JC; Laraia MT; Bissette G; Nemeroff CB
    Biol Psychiatry; 1996 Apr; 39(8):703-7. PubMed ID: 8731457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cortisol in the CSF of depressed and suicidal patients.
    Träskman L; Tybring G; Asberg M; Bertilsson L; Lantto O; Schalling D
    Arch Gen Psychiatry; 1980 Jul; 37(7):761-7. PubMed ID: 6156664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma catecholamines and their metabolites in obsessive-compulsive disorder.
    Benkelfat C; Mefford IN; Masters CF; Nordahl TE; King AC; Cohen RM; Murphy DL
    Psychiatry Res; 1991 Jun; 37(3):321-31. PubMed ID: 1891512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.